Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials-Reference-Cited by-同舟云学术

Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials

Published:2007-01-16 Issue:0 Volume:0 Page:070116065049004
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Saha S. A.,Molnar J.,Arora R. R.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2006.00688.x/fullpdf

Reference67 articles.

1. 1 Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States , 2005 . Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. Available online athttp://www.diabetes.org/uedocuments/nationaldiabetesfactsheetrev.pdf. Accessed 25 June 2006.

2. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis

3. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension;Cochrane Database of Systematic Reviews;2018-11-14

2. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care;Journal of Managed Care & Specialty Pharmacy;2016-01

3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension;Cochrane Database of Systematic Reviews;2015-01-11

4. Dual Renin-Angiotensin-Aldosterone Blockade: Promises and Pitfalls;Current Hypertension Reports;2014-12-02

5. Safety during the monitoring of diabetic patients: trial teaching course on health professionals and diabetics - SEGUDIAB study;BMC Public Health;2011-06-05